NDC 10742-8158-02: Rohto Max Strength Naphazoline hydrochloride, Polysorbate 80 .3 mg/mL; 80 2 mg/mL Liquid
This is a package of Rohto Max Strength Naphazoline hydrochloride, Polysorbate 80 .3 mg/mL; 80 2 mg/mL Liquid from The Mentholatum Company, first listed with the FDA May 2021 and currently FDA-listed.
NDC database record
One package, one record: these facts belong to NDC 10742-8158-2 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 10742 labeler · 8158 product · 2 package
- Package marketed since
- May 12, 2021
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2027
- Barcode (UPC)
- 0310742011012
- FDA record last changed
- Nov 12, 2026
Other active recalls for Naphazoline Hydrochloride, Polysorbate 80 (different manufacturers) — 1 · tap to view
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 1535485
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
RxNorm drug class
This medicine belongs to the Sympathomimetics, plain class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Nov 19, 2026
Clinical
Rohto Max Strength is an over-the-counter eye drop liquid sold under FDA's OTC monograph rules. It contains naphazoline hydrochloride, a decongestant typically used to reduce redness and relieve minor eye irritation, and polysorbate 80, which functions as a lubricant and preservative in the formulation. This product is applied directly to the eye surface to provide temporary relief of symptoms like redness and discomfort.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 10742-8158-01 10742-8158-1 Main listing | 1 BOTTLE, WITH APPLICATOR in 1 CARTON / 13 mL in 1 BOTTLE, WITH APPLICATOR | 2021-05-12 | — | Active |
| 10742-8158-02 You're viewing this | 2 BOTTLE, WITH APPLICATOR in 1 CARTON / 13 mL in 1 BOTTLE, WITH APPLICATOR | 2021-05-12 | — | Active |
Pack size FAQ
What quantity is in this package?
What NDC number is used to bill for this package of Rohto Max Strength Naphazoline hydrochloride, Polysorbate 80 .3 mg/mL; 80 2 mg/mL Liquid?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Rohto Max Strength .3 mg/mL; 80 2 mg/mLthis 10742-8158-02 | The | 2 bottles | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
1 mg / 1 mL
UNII 3K9958V90M
A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
-
UNII F5UM2KM3W7
Benzalkonium chloride is a chemical compound that works as a preservative and antimicrobial agent in medications. It prevents bacterial and fungal growth in liquid formulations to keep the product safe during storage and use.
-
UNII R57ZHV85D4
Boric acid is a weak acid derived from boron. In medicines, it typically serves as a buffer to help maintain the product's pH level and may act as a preservative in certain formulations.
-
UNII HM4YQM8WRC
Chlorobutanol is a colorless crystalline chemical used as a preservative in medicines. It prevents bacterial and fungal growth to maintain product safety and shelf life.
-
UNII 7FLD91C86K
Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
-
UNII L7T10EIP3A
A cooling compound from mint plants used as a flavoring agent and to create a fresh sensation in medicines. It helps mask bitter tastes and improve how the product feels in the mouth.
-
UNII OC4598NZEQ
Potassium aspartate is a salt compound that provides potassium and aspartic acid. It serves as a mineral supplement ingredient and electrolyte source in medications and formulations.
-
UNII 91MBZ8H3QO
Sodium borate is an inorganic salt compound used in medicines as a buffer to help maintain a stable pH level, and sometimes as a mild preservative or cleansing agent in topical formulations.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
9 inactive ingredients listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from The Mentholatum Company labeler code 10742
- WellPatch Cooling Pain Relief menthol 50 mg Patch NDC 10742-8125-1
- WellPatch Warming Pain Relief capsaicin 25 mg Patch NDC 10742-8127-1
- Rohto Sun and Sport hypromellose, povidone 3 mg/mL; 5 mg/mL Liquid NDC 10742-8140-1
- Rohto Cool Relief Naphazoline hydrochloride, Polysorbate 80 .12 mg/mL; 80 2 mg/mL Liquid NDC 10742-8141-1
- Rohto Cool Naphazoline hydrochloride, Polysorbate 80 .12 mg/mL; 80 2 mg/mL Liquid NDC 10742-8142-1
- Rohto All-In-One Hypromellose, Tetrahydrozoline hydrochloride, Zinc sulfate 2 mg/mL; .5 mg/mL; 2.5 mg/mL Liquid NDC 10742-8146-1
- Rohto Optic Glow Naphazoline hydrochloride, Povidone, Propylene glycol .3 mg/mL; 5 mg/mL; 2 mg/mL Liquid NDC 10742-8160-1
- Rohto Preservative Free Dry Aid povidone, propylene glycol 6.8 mg/mL; 3 mg/mL Liquid NDC 10742-8161-1
- Rohto Dry-Aid povidone, propylene glycol 6.8 mg/mL; 3 mg/mL Liquid NDC 10742-8162-1
- Mentholatum Nighttime Vaporizing Rub camphor, eucalyptus oil, menthol 53 mg/g; 13 mg/g; 28 mg/g Ointment NDC 10742-8168-1
- Mentholatum Pain Relieving menthol, methyl salicylate 60 mg/mL; 200 mg/mL Lotion NDC 10742-8169-1
- Rohto Digi-Eye Hypromellose, Tetrahydrozoline hydrochloride 3.5 mg/mL; .5 mg/mL Liquid NDC 10742-8175-1
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Uses relieves redness of the eye due to minor eye irritations temporarily relieves burning and irritation due to dryness of the eye for protection against further irritation
⏱️ Dosage and Administration ▾
Directions put 1 or 2 drops in the affected eye(s) up to 4 times daily tightly snap on cap to seal Other information do not store above 25°C (77°F)
⚠️ Warnings and Cautions ▾
When using this product do not touch tip of container to any surface to avoid contamination replace cap after each use do not use if solution changes color or becomes cloudy overuse may cause more eye redness pupils may become enlarged temporarily remove contact lenses before using
⚠️ Warnings ▾
Warnings For external use only Ask a doctor before use if you have narrow angle glaucoma When using this product do not touch tip of container to any surface to avoid contamination replace cap after each use do not use if solution changes color or becomes cloudy overuse may cause more eye redness pupils may become enlarged temporarily remove contact lenses before using Stop use and ask a doctor if you feel eye pain changes in vision occur redness or irritation of the eyes lasts condition worsens or lasts more than 72 hours Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
🧪 Active Ingredient ▾
Active ingredients Naphazoline hydrochloride 0.03% Polysorbate 80 0.2%
🧪 Inactive Ingredients ▾
Inactive ingredients alcohol (0.1%), benzalkonium chloride, boric acid, chlorobutanol, edetate disodium, menthol, potassium aspartate, purified water, sodium borate
🎯 Purpose ▾
Purpose Naphazoline hydrochloride - Redness reliever Polysorbate 80 - Lubricant
📄 Ask a Doctor Before Use If ▾
Ask a doctor before use if you have narrow angle glaucoma
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if you feel eye pain changes in vision occur redness or irritation of the eyes lasts condition worsens or lasts more than 72 hours
📄 Keep Out of Reach of Children ▾
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
📄 Questions or Comments ▾
Questions? 1-877-636-2677 MON-FRI 9 AM - 5 PM (EST)
📄 Package Label / Principal Display Panel ▾
Package Label / Principal Display Panel Image 1
Reported adverse events (FAERS)
Top reported reactions
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |